PharmAust - Now that is impressive, page-88

Agree. The IP alone is worth that... forget everything else they are doing. Seriously undervalued at the moment. Anyone getting in at 12-14 are going to make bank in the next few months. I think we are going to see a big steering of the ship at the AGM, I also wouldn't be surprised if we get a positive announcement or trading halt before the AGM with some really good news.

Below is pure speculation based on my observations over the past year:

*Positive results from the Covid report - 16-18c

*Recruiting more dogs which pretty much guarantees more positive results based on the previous trial should easily value around 16-18c

*Starting phase I trails of MND alone should put us back toward 15-20c range.

*Throw in any surprise announcements regarding a doggie partner - 25-30c

All these in my opinion is still extremely conservative and undervalued and not to mention all the cancer work they are doing.

Any commercial partner/deal re: covid or the dogs easily 50-70c, if it's a leading covid treatment after all this $1-$2+ with a possible t/o bid in the works.

Just my thoughts.